Pro-permeability Factors in Diabetic Macular Edema; the Diabetic Macular Edema Treated with Ozurdex Trial

PURPOSE: The Diabetic Macular Edema Treated with Ozurdex (DMEO) Trial measured aqueous pro-permeability factors (PPFs) in diabetic macular edema (DME) patients before and after injection of dexamethasone implant or vascular endothelial growth factor (VEGF)-neutralizing protein and correlated changes...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Am J Ophthalmol
Autores principales: Campochiaro, Peter A., Hafiz, Gulnar, Mir, Tahreem A., Scott, Adrienne W., Zimmer-Galler, Ingrid, Shah, Syed M., Wenick, Adam S., Brady, Christopher J., Han, Ian, He, Lingmin, Channa, Roomasa, Poon, David, Meyerle, Catherine, Aronow, Mary Beth, Sodhi, Akrit, Handa, James T., Kherani, Saleema, Han, Yong, Sophie, Raafay, Wang, Guohua, Qian, Jiang
Formato: Artigo
Lenguaje:Inglês
Publicado: 2016
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5482180/
https://ncbi.nlm.nih.gov/pubmed/27130369
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajo.2016.04.017
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares